Riskpilot← Back to searchSign inGet full accessØYELEGE SIGMUND BIRKELAND AS
ASActiveOrg 915577229Stoaveien 5B, 4848 ArendalMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2024
NOK 4,3M
-2% vs 2023
EBITDA margin
35.7%
+8% vs 2023
Equity ratio
64.0%
Financial strength
Net profit 2024
NOK 1,1M
+13% vs 2023
| Revenue | NOK 4,3M | -2% |
| EBITDA | NOK 1,5M | +8% |
| Net profit | NOK 1,1M | +13% |
| Total assets | NOK 4,2M | +3% |
| Equity | NOK 2,7M | +9% |
| Employees | 1 | — |
Legal name
ØYELEGE SIGMUND BIRKELAND AS
Org number
915577229
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
23. juni 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utøve spesialiserte legetjenester, herunder øyelegevirksomhet, samt det som naturlig står i forbindelse med dette.
Address
Stoaveien 5B, 4848 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 861 | 4 623 | 4 097 | 4 335 | 4 264 |
| Staff expenses | −1 083 | −856 | −621 | −741 | −635 |
| EBITDA | 1 223 | 1 641 | 1 316 | 1 404 | 1 521 |
| Depreciation & amort. | −98 | −258 | −211 | −154 | −121 |
| EBIT | 1 125 | 1 383 | 1 104 | 1 250 | 1 399 |
| Net financials | 1 | 2 | 3 | 22 | 37 |
| Profit before tax | 1 127 | 1 385 | 1 108 | 1 272 | 1 437 |
| Tax | 249 | 305 | 244 | 280 | 316 |
| Net profit | 877 | 1 080 | 864 | 992 | 1 120 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 182 | 3 475 | 3 639 | 4 124 | 4 246 |
| Equity | 2 034 | 2 190 | 2 304 | 2 495 | 2 716 |
| Long-term debt | 43 | 34 | 24 | 19 | 18 |
| Short-term debt | 1 104 | 1 251 | 1 311 | 1 609 | 1 512 |
| Total debt | 1 147 | 1 285 | 1 335 | 1 629 | 1 530 |
EBITDA margin
35.7%
This company
15.8%
Market median
+126% vs market
20202024
Equity ratio
64.0%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
41.3%
This company
18.4%
Market median
+124% vs market
20202024
Net profit margin
26.3%
This company
8.1%
Market median
+225% vs market
20202024
Asset turnover
1.00×
This company
1.12×
Market median
+11% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2015 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ØYELEGE SIGMUND BIRKELAND AS (this company)
Arendal Øyelegesenter AsBoard members of ØYELEGE SIGMUND BIRKELAND AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigmund Jan Birkeland | Chief Executive Officer | 0 companies |